establishment of collateral anastomosis, and repair of vessel trauma (45) . However, the number of EPCs in some patients with cardiovascular disease is reduced and EPC function is attenuated as a consequence of exposure to risk factors (38) . Recently, EPC transplantation has become a potential therapy for treatment of ischemic disease (20) . Several studies show that EPC transplantation provides a modest benefit for treatment of myocardial infarction (19, 41) , limb ischemia (21) , and diabetic retinopathy (6) , compensating for a shortage of endogenous EPCs. Angiogenic effects of the transplanted EPCs include differentiation into endothelial cells and production of cytokines that stimulate the existing endothelial cells to form new vessels through paracrine effects.
Several different approaches to cell-based therapies have been limited by poor survival of the engrafted cells (9) . For example, at day 4 after engraftment into the left ventricle of mice, only 0.44% of infused human mesenchymal stem cells (MSCs) were found within the myocardium (43) . Intra-arterially delivered rat MSCs decreased to 14% of their initial numbers at day 3 (44) . In rat models of myocardial infarction, only 0.1% of bone marrowderived stromal cells remained after intramyocardial injection for 10 wk and ϳ0.1% of cells were detected after intravenous infusion for 6 wk (7). At 4 wk after transplantation, MSCs were not present in scar tissue of infarcted rat hearts (2) . In patients with myocardial infarction, only 1.3 to 2.6% of unfractionated bone marrow cells and 14%-39% of CD34-enriched cells remained after intracoronary transfer (16) . Cumulatively, these animal and human studies suggest that benefits of cell therapy are limited by massive death of engrafted cells. To improve these outcomes, it is necessary to elucidate mechanisms of EPC survival after transplantation and to find new ways for improving survival of the implanted cells.
Autophagy is a cellular pathway involved in protein and organelle degradation, with connections to human physiology and disease (25) . Autophagy may be divided into macroautophagy, microautophagy, and chaperone-mediated autophagy based on the pathways by which cargo is delivered into lysosomes. In macroautophagy, the autophagosome precursor encompasses a portion of the cytoplasm or organelles and then closes to form the autophagosome. The autophagosome fuses with the lysosome to form an autolysosome where the engulfed cargo and the inner membrane of the autophagosome are degraded by acid hydrolases (3) . Autophagy occurs at basal, constitutive levels and is upregulated under physiological stress such as nutrient deprivation and growth factor withdrawal (26) . Under these conditions, autophagy plays important roles in getting rid of the degenerated or senescent organelles and aggregation-prone proteins and supplying energy for cellular activities. Autophagy malfunction contributes to the pathogenesis of cardiovascular and neurodegenerative disorders (31) . In ischemic cell injury, upregulation of autophagy delays both apoptosis and necrosis (22) . Uncontrolled autophagy may lead to cell death, presumably due to excessive degradation of cellular constituents (31) . Recently, in vitro experiments have demonstrated that autophagy of endothelial cells promotes angiogenesis (10) . However, whether autophagy plays a cytoprotective role in the proliferation, differentiation, and survival of EPCs in a hypoxic environment is unclear.
This investigation was designed to examine changes in macroautophagy (hereinafter termed "autophagy") of cord bloodderived EPCs during differentiation into endothelial cells and to evaluate the effects of autophagy on EPC survival after hypoxia treatment. 1 Because the number of dying or dead cells increases significantly after long-term hypoxia, the results of experiments in determining the protective effect of autophagy on EPC survival may be difficult to discern. Therefore, cells were treated with short-term severe hypoxia (1% O 2 , 2 h). Here we report that inhibition of autophagy reduces proliferation and differentiation of EPCs under normoxic conditions. Under hypoxic conditions, the level of autophagy of EPCs increases significantly, and enhancement of autophagy increases EPC survival.
MATERIALS AND METHODS
Isolation of mononuclear cells. The present study was approved by the Ethics Committee of Shanghai Health Hospital for Women and Children. Written informed consent was obtained from the parents of the newborns. Human umbilical cord blood samples were collected from normal full-term deliveries. Sodium heparin (10 U/ml) was added into blood for anticoagulation. After being allowed to settle for 30 min at room temperature, the upper part of blood was layered onto 1.076 Percoll solution (Amersham Pharmacia Biotech, Uppsala, Sweden). After centrifugation for 30 min at 360 g, the mononuclear cells were harvested. The cells were resuspended in Dulbecco's modified Eagle's medium (DMEM; Invitrogen) supplemented with 50 ng/ml vascular endothelium growth factor (VEGF; R&D Systems), 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 g/ml streptomycin. Then, the cells were seeded into gelatin-coated culture dishes at a density of 1 ϫ 10 5 cells/cm 2 and incubated in a 5% CO2 humidified incubator at 37°C. Half of the medium was changed with the complete medium every 2 or 3 days.
Sorting of EPCs. After incubation for 7 days, the cells were harvested by digestion with 0.125% trypsin and 0.01% EDTA. The suspended cells were incubated with polyclonal rabbit anti-human vascular endothelial growth factor receptor-2 (VEGFR-2) antibody and mouse anti-human CD34 antibody (1:100; Diagnostica) or mouse anti-human CD133 antibody (1:100; Diagnostica) for 50 min at 4°C. After being washed, the cells were incubated with goat anti-rabbit IgG-PE and goat anti-mouse IgG-FITC (1:100; Chemicon) for 30 min at 4°C. Following centrifugation for 10 min at 250 g, the cells were resuspended with DMEM containing 2.5% FBS, CD34
ϩ VEGFR-2 ϩ and CD133 ϩ VEGFR-2 ϩ cells were analyzed by flow cytometry, and CD34 ϩ VEGFR-2 ϩ cells were collected by cell sorting (FACS Aria, BD Biosciences). Differentiation of EPCs into endothelial cells was determined by acquisition of CD31 expression using immunostaining after incubation for 2 wk.
Proliferation assay. Synchronization of the cells was performed with the method described by Olszewska et al. (27) . When cells reached 80% confluence, they were incubated for 6 h at 4°C. The cells were collected and randomly divided into control and 3-methyladenine (3-MA) treatment groups. For the latter, 5 mM 3-MA (Sigma), an inhibitor of class III PI3K that prevents formation of autophagosomes, was added to the medium (30) . Subsequently, cells were returned to normal growth conditions and incubated for an additional 12 h before harvest. After addition of precooled 95% ethanol, the cells were placed at 4°C overnight. The cells were mixed with 1 ml propidium iodide (PI; 1 mg/ml; Sigma, Deisenhofen, Germany) and then incubated at 4°C for 20 min. After centrifugation, the cells were resuspended at 2 ϫ 10 6 cells/ml. Cell cycle was analyzed immediately MTT assay. Assessment of cell proliferation ability was performed according to the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] assay. The cells were seeded in a 96-well plate at a density of 4 ϫ 10 3 cells/well, three parallel wells for each group. The cells were divided into control and 3-MA groups. In the 3-MA group, cells were pretreated with 5 mM 3-MA for 1 h. At 12, 24, 36, and 48 h after incubation, 5 mg/ml MTT (Sigma) was added to the wells, and the cells continued to be incubated for 4 h. After aspiration of the medium, formazan salt in the well was dissolved with 150 l dimethylsulfoxide (Sigma). Absorbance values were determined at 570 nm with an ELISA reader, and a growth curve for the cells was established. The experiment was repeated three times in each group. To examine the changes of differentiation of EPCs toward endothelial cells after inhibition with 3-MA, changes in the expression of CD31 in the cells were examined at day 14 after induction with VEGF.
Hypoxic treatment. The sorted cells were incubated for 24 h. The cells were divided into control, hypoxia 30 min, hypoxia 1 h, hypoxia 2 h, and 3-MA groups. In the hypoxia groups, the culture dishes were put into a hypoxia chamber (Billups-Rothenberg, San Diego, CA), flushed with a gas mixture of 1% O 2, 5% CO2, and 94% N2, and maintained at 37°C for 30 min, 1 h, and 2 h, respectively. Oxygen concentration was measured with an oxygen analyzer (BillupsRothenberg) (13) . In the 3-MA group, cells were pretreated with 5 mM 3-MA for 1 h and then subjected to hypoxia for 1 h. Autophagy and apoptosis of the hypoxic cells were compared with control cells in the following assays.
Expression of Beclin-1. Beclin-1, a phylogenetically conserved protein, is regarded as a specific autophagic gene. To assess expression of Beclin-1, cells were fixed with 4% paraformaldehyde for 10 min and then permeabilized with 0.25% Triton X-100 in PBS for 10 min. Cells were then washed and incubated with polyclonal antibody against Beclin-1 (1:200; Proteintech Group, Chicago, IL) overnight at 4°C. Subsequently, the cells were incubated with FITC-labeled IgG for 1 h and the nuclei were counterstained with DAPI (1:1,000; Sigma) at room temperature. Intensity of fluorescence-labeled Beclin-1 in the cells was examined with a confocal laser scanning microscope.
To examine Beclin-1 mRNA expression, total RNA from the hypoxia-treated cells was extracted using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. Primers specific for the human Beclin-1 gene were used (human Beclin-1 primers forward, 5=-CAAGATCCTGGACCGTGTCA-3= and reverse, 5=-TGGCAC-TTTCTGTGGACATCA-3=). The first-strand cDNA was synthesized using T-primed first strand kit (Amersham Pharmacia Biotech) and then amplified by Taq DNA polymerase (Advantage cDNA Polymerase Mix, Invitrogen) in 20 l reaction mixture containing 10 ml 2ϫ Master Mix (Invitrogen), 5 pM Beclin-1 primers (or 6 pM GAPDH primers), and 1 l (25 ng) of cDNA. Reverse transcriptase-polymerase chain reaction (RT-PCR) was performed using a PCR thermal cycler (MWG Biotech, Ebersberg, Germany). After a reverse transcription reaction at 70°C for 15 min and an initial denaturation at 95°C for 15 min, a 40-cycle PCR reaction was carried out using the following amplification profile: denaturation at 94°C for 45 s, annealing at 58°C for 45 s, extension at 72°C for 45 s. For GAPDH primers, a 35-cycle amplification was performed with annealing at 63°C. Then, the PCR products were electrophoresed on 1.5% agarose gel, stained with 0.5 g/ml ethidium bromide, visualized under ultraviolet light, and photographed. Changes of Beclin-1 expression were determined with MxPro quantitative PCR software (version 4.0; Stratagene).
MDC staining. Autophagosomes in the cells were detected with monodansylcadaverine (MDC) staining using the method as previously described (5) . Briefly, the cells were incubated with 0.05 mM MDC (Sigma) in Hanks' buffered salt solution at 37°C for 10 min. After being washed three times with 0.1 M PBS, MDC-labeled autophagosomes were examined with a confocal laser scanning microscope. The cells containing MDC-labeled autophagosomes were counted in ϫ100 fields (five sequential fields were counted and averaged per coverslip) for three coverslips in each experiment as a percentage of total cell number.
LC3 staining. Microtubule-associated protein 1 light chain 3 (LC3) is expressed mainly on autophagosome and is used as a specific marker for autophagic structures (18) . To assess LC3 localization, the cells were fixed in 4% paraformaldehyde and then permeabilized with 0.5% Triton X-100. Nonspecific binding sites were blocked with goat serum. The cells were incubated with polyclonal antibody against LC3 (1:200; Santa Cruz Biotechnology) overnight at 4°C and with IgG-FITC (1:100; Santa Cruz Biotechnology) at 37°C for 30 min. The nuclei were stained with PI. LC3-positive puncta were viewed with a confocal laser scanning microscope and counted in ϫ100 fields (five sequential fields were counted and averaged per coverslip) for three coverslips.
Transmission electron microscopy. To prepare cells for analysis by transmission electron microscopy, a pellet of cells was prefixed with 2.5% glutaraldehyde in 0.1 M PBS overnight at 4°C and postfixed in 1% buffered osmium tetroxide. Then, the specimens were dehydrated through graded ethanol and embedded in epoxy resin. Ultrathin sections were prepared and stained with uranyl acetate and lead citrate. Autophagosome precursors, autophagosomes, and autolysosomes in the cells were examined with a transmission electron microscope (CM120, Philips, Eindhoven, Holland). Sectional areas of the autophagic structures were measured with a VLCDS image analyzer (Leica), and the ratios of the cross-sectional area of the autophagic structures to that of the cytoplasm were calculated. The autophagic structures were examined in 200 cells for each group.
Labeling of lysosomes. To evaluate the relation of lysosomes to the formation of autophagic structures, lysosomes in the cells were labeled with LysoSensor green (Invitrogen). After hypoxia treatment, the cells were incubated in 1 M prewarmed LysoSensor green for 30 min. Hoechst 33342 (1:1,000; Invitrogen) was added to the dishes and the cells continued to be incubated for 20 min. The loading solution was then replaced with DMEM, and the distribution of the labeled lysosomes was examined using a confocal laser scanning microscope. Lysosomes were counted in 20 cells (five sequential ϫ100 fields were counted and averaged per culture dish) for three culture dishes.
Analysis of apoptosis. The cells were divided into control, hypoxia, and 3-MA groups. In the hypoxia group, cells were treated with hypoxia as above for 1 h. In the 3-MA group, cells were treated as above. The cells were incubated with 1 g/ml FITC-Annexin V (BD Biosciences) and 1 g/ml PI for 10 min. The apoptotic cells were analyzed by flow cytometry. For ethidium bromide and acridine orange (EB/AO) staining, a suspension of the cells was dropped onto slides, and a mixture of EB and AO solutions was then added. The stained cells were immediately examined using a fluorescent microscope. The percentages of viable, early apoptotic, late apoptotic, and necrotic cells were calculated respectively by the following formula: percentage (%) ϭ number of viable, early apoptotic, late apoptotic, or necrotic cells/number of all counted cells (32) . The experiment was repeated three times.
In another experiment, the cells were divided into control, hypoxia, and rapamycin groups. In the hypoxia group, cells were incubated with 1% O 2 for 2 h. In the rapamycin group, cells were pretreated with 50 nM rapamycin from Strepomyces hygroscopicus (Sigma) for 2 h before hypoxia treatment. Rapamycin, a specific inhibitor of mTOR, induces cell autophagy. After being washed, the cells were incubated with FITC-Annexin V and PI as above. The apoptotic cells were analyzed by flow cytometry.
Statistical analysis. Statistical analysis was performed with SPSS software (version 12.0). Data are presented as means Ϯ SD and were calculated from at least three separate experiments, and each experiment was performed in triplicate. The normality of the data was analyzed by Kolmogorov-Smirnov test. Mean comparisons were analyzed by Student's t-test of independent samples and one-way analysis of variance with Scheffé's post hoc multiple-comparison analysis to compare the mean between different groups. The level of significance accepted was P Ͻ 0.05. (Fig. 1A) . VEGFR-2, CD133, and CD34 were expressed on EPC membrane (Fig. 1B) . The freshly sorted CD34 ϩ VEGFR-2 ϩ EPCs were round or oval. Under induction with VEGF, the cells could proliferate and differentiate toward endothelial cells. At day 10 after induction with VEGF, some cells appeared spindle-like or polygonal (Fig. 1C) . Positively sorted CD34 ϩ VEGFR-2 ϩ cells were used in the following experiments.
RESULTS

Biologic characteristics of
Effects of autophagy on proliferation and differentiation of EPCs. Cell cycle was analyzed with flow cytometry (Fig. 2A) . The proliferation index of the cells in the control group was 24.06 Ϯ 3.25%. After treatment with 3-MA, the proliferation index of the cells decreased to 13.55 Ϯ 3.71%. The difference between the two groups was significant (Table 1) . By MTT assay, the viability of the cells decreased after treatment with 3-MA. Differences in cell viability at 24, 36, and 48 h after incubation between 3-MA and control groups were significant (Fig. 2B) . 3-MA-treated cells did not differentiate into endothelial cells at day 14 after induction with VEGF (data not shown).
Beclin-1 expression of EPCs after hypoxia treatment. By immunostaining, Beclin-1 appeared in a granular and homogeneous pattern and was found almost exclusively in the perinuclear region. Compared with the control cell group, Beclin-1 expression of the cells subjected to hypoxia increased. Beclin-1 expression increased as hypoxic conditions were extended. After pretreatment with 3-MA, Beclin-1 expression of the hypoxic cells was inhibited (Fig. 3A) . By RT-PCR analysis, the level of Beclin-1 mRNA expression was significantly higher in hypoxic cells than in the control group. Differences in Beclin-1 mRNA expression among the three hypoxia groups were significant. In the 3-MAtreated group, Beclin-1 mRNA expression was reduced (Fig. 3B) .
Changes of autophagic structures in hypoxia-treated cells. By cytochemical staining, MDC was concentrated in round or oval structures. Compared with the control group, the number of cells containing MDC-labeled autophagic structures in the hypoxic groups was greater. Differences in the number of cells containing MDC-labeled structures among the three hypoxia groups were significant. When cell autophagy was inhibited with 3-MA, the number of cells containing MDC-labeled structures was decreased (Fig. 4, A and B) .
Autophagic structures labeled with LC3 immunostaining were round or oval. The number of LC3-positive puncta in the cells in the hypoxic groups was greater than that in the control group. There were significant differences in the number of puncta among the hypoxia groups. In the 3-MA-treated group, the puncta were reduced (Fig. 4, C and D) .
Changes of autophagic ultrastructures in hypoxia-treated cells. Autophagic ultrastructures were examined by transmission electron microscopy. Representative autophagic structures in hypoxia-treated cells are shown in Fig. 5 . Autophagosome precursors present double-membrane structures that are crescentiform or cuplike (Fig. 5, A and B) . Autophagosomes are round or oval double-membrane structures, which encompass electron lucent cytoplasm or dense organelles (Fig. 5C ). Autophagosomes with multilayer membranes were observed occasionally (Fig. 5D ). In autolysosomes, the lysosome contains an autophagosome that has a single membrane (Fig. 5F ). Microautophagy occurred in some hypoxic cells (Fig. 5E) . Ratios of the cross-sectional areas of the autophagic structures to that of the cytoplasm in hypoxia groups were significantly higher than in the control group. There were significant differ- ences in the ratios among the hypoxia groups. After treatment with 3-MA, the ratios of the autophagic structures in the hypoxic cells were decreased ( Table 2) .
Changes in number of lysosomes after hypoxia treatment. The difference in the number of lysosomes between the control group and the hypoxic 30 min group was not significant. However, compared with the control group, lysosomes in the hypoxic 1 h and the hypoxic 2 h groups increased significantly. The number of lysosomes in the hypoxic 2 h group were greater than that in the hypoxic 1 h group. In the 3-MA-treated group, lysosomes were smaller and fewer (Fig. 6) .
Changes in apoptosis after inhibition of autophagy. To assess cell death by flow cytometric analysis, cells were stained with FITC-Annexin V and PI. The number of apoptotic cells in the cells treated with hypoxia for 1 h was increased compared with the control group. Compared with the hypoxic group, the apoptotic cells in the 3-MA group increased significantly (Fig. 7, A and B) .
By EB/AO staining, the nuclei of normal cells are uniformly green. Early apoptotic cells have shrunken and chromatincondensed nuclei, while the nuclei of late apoptotic cells are orange-red in color, and the nuclei of necrotic cells appear uniformly red. Early and late apoptotic cells in the hypoxic groups were more frequent than in the control group. After pretreatment with 3-MA, the apoptotic cells in the hypoxic cells increased significantly (Fig. 7C) . The numbers of the necrotic cells were 0.1 Ϯ 0.0%, 0.5 Ϯ 0.1%, and 1.3 Ϯ 0.1% in control, hypoxia, and 3-MA groups, respectively.
Effect of enhanced autophagy on inhibition of hypoxiainduced apoptosis. Enhancement of autophagy of the cells was achieved by pretreatment with rapamycin. The apoptotic cells among the cells treated with hypoxia for 2 h increased obviously. Compared with the hypoxic group, the apoptotic cells in the rapamycin-treated group were significantly reduced (Fig. 8) . In the control, hypoxia, and rapamycin groups, there were 0.8 Ϯ 0.1%, 2.7 Ϯ 0.5%, and 0.8 Ϯ 0.3% necrotic cells, respectively.
DISCUSSION
In this study, we demonstrate that autophagy is involved in EPC proliferation and differentiation. After basal autophagy was inhibited with 3-MA, proliferation and viability of EPCs were reduced and the cells failed to differentiate into endothelial cells. Basal autophagy is important for maintaining normal cellular homeostasis. Currently, there is growing evidence for a role of autophagy in the control of cell proliferation (47) . Following growth factor withdrawal, autophagy increases and cell size declines in the G 0 /G 1 arrested cells (23) . Autophagy is strongly inhibited in mitosis cells, and autophagic vacuoles appear after closure of the nuclear envelope in telophase/G 1 (11) .
After treatment with inducers, autophagic cells increase in S phases, diminish in G 2 /M phase, and attain maximum values in G 1 phase (42) . These studies show that autophagy is most active in the G 1 and S phases of the cell cycle and inhibited in mitosis. In cell differentiation, recent studies suggest that autophagy is involved in erythropoiesis, lymphopoeisis, and adipogenesis (24) . Autophagy promotes the generation and differentiation of induced pluripotent stem cells (46) . Blocking autophagy abolishes self- renewal and differentiation of adult stem cells (35) . The results of our experiments suggest that autophagy plays an important role in the proliferation and differentiation of stem/progenitor cells. In recent years, the proliferation and differentiation of stem cells in a hypoxia microenvironment have been investigated intensively (40) . Most stem/progenitor cells reside in discrete low O 2 niches, which is required to maintain the full differential potential (29) . Hypoxia enhances the generation of induced pluripotent stem cells (48) . Low O 2 concentration (0.1%) induces the G 0 return of CD34 ϩ cells derived from cord blood (15) . Differentiation of human embryonic stem cells is markedly reduced under hypoxic conditions (12) . Interestingly, autophagy is critical for limiting cell growth and promoting cell survival in times of stress (47) . Proliferation and differentiation are the main characteristics of EPC growth and crucial steps for EPC-induced angiogenesis. Therefore, effects of autophagy on proliferation and differentiation of EPCs could be important for angiogenesis of ischemic tissue.
Our experimental data show that levels of autophagy were enhanced in hypoxic cells compared with normoxic cells. During treatment with short-term severe hypoxia (1% O 2 , 30 min, 1 h, or 2 h), expression of Beclin-1, MDC-, and LC3-positive puncta, and autophagic ultrastructures all increased in a time-dependent fashion. When autophagy of hypoxic cells was inhibited with 3-MA, the number of apoptotic cells increased. Hypoxia-inducible factor 1 (HIF-1), a heterodimeric transcription factor, plays an essential role in the maintenance of oxygen homeostasis (37) . HIF-1 mediates adaptive responses to reduced oxygen availability by reduced mitochondrial mass and/or metabolism, which contributes to the protective effects of ischemic preconditioning (28) . Hypoxia-induced mitochondrial autophagy requires HIF-1-dependent expression of Beclin-1 and BNIP3 (4, 50) . Autophagy removes the damaged mitochondria, thereby reducing reactive oxygen species production and DNA damage and inhibiting the release of proapoptotic factors such as cytochrome c (36) . The results in this study provide evidence that autophagy induced by shortterm hypoxia protects EPCs, promoting survival and inhibiting apoptosis. Recently, ischemic cell injury experiments showed that mild ischemia leads to induction of autophagy and apoptosis, while moderate or severe ischemia induces both apoptotic and necrotic cell death (22) . Autophagic changes of EPCs exposed to more prolonged hypoxia will need further investigation.
Lysosomes are ubiquitous organelles that constitute the primary degradative compartments of the cell, receiving substrates through endocytosis, phagocytosis, or autophagy (34) . In our experiments, the lysosomes in hypoxia-induced cells increased as autophagy was enhanced. After treatment with 3-MA, the number and size of lysosomes decreased markedly. Extensive autophagy generates proto-lysosomal tubules and vesicles that extrude from autolysosomes and ultimately mature into functional lysosomes, thereby restoring the full complement of lysosomes (49) . Effective biogenesis of the lysosome is implicated in meeting the demand of enhanced cell autophagy in hypoxic conditions.
The present study suggests that the activation of autophagy promotes the resistance of EPCs to hypoxia for survival. Rapamycin in high concentrations inhibits cell proliferation (39) . Therefore, low concentrations of rapamycin were used for activating autophagy in this study. Current research focuses on optimization of stem cell transplantation with preconditioning (14) . Hypoxic preconditioning of MSCs reduces apoptosis of the implanted cells, enhancing repair of the infarcted myocardium (17) . Preculturing under hypoxic conditions prior to transplantation increases motility and improves tissue regenerative potential of MSCs (33) . MSCs exposed to low O 2 express prosurvival, proangiogenic, and prodifferentiation proteins significantly (8) . Biological characteristics of EPCs are different from that of mature endothelial cells and other progenitor/stem cells. By limiting oxygen consumption, the oxygen uptake rate of human EPCs is low in hypoxic culture. Oxygen consumption of human EPCs is similar to that of human umbilical vein endothelial cells and lower than that of human embryonic stem cells and induced pluripotent stem cells (1) . Since EPCs may maintain survival in a hypoxic microenvironment by autophagic mechanisms, it may be possible to develop strategies to augment survival and differentiation of homing or transplanted EPCs. According to the results of our experiments, we suggest that the contribution of autophagy to hypoxic preconditioning may be beneficial for adaptation of the transplanted EPCs to the ischemic microenvironment.
